Research
Withaferin A suppresses malignant progression of leukemia by reducing promoter methylation levels
Nature ·
The Brief
- A nature.com subject feed item reports that Withaferin A suppresses malignant progression of leukemia by reducing promoter methylation levels.
- The feed item contains no summary, so the study design, models and effect sizes are not available from the sources.
- The item is dated 2026-11-13 in the nature.com biological sciences feed.
Why it matters
The headline points to promoter methylation, an epigenetic mechanism, as a possible target in leukemia, but the sources give no detail beyond that claim.
Who’s affected
- cancer researchers
- epigenetics researchers